CapCof is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Capital Pharmaceutical, Llc. The primary component is Codeine Phosphate; Phenylephrine Hydrochloride; Chlorpheniramine Maleate.
| Product ID | 29978-420_61473186-c2f3-780e-e053-2a91aa0a57aa |
| NDC | 29978-420 |
| Product Type | Human Otc Drug |
| Proprietary Name | CapCof |
| Generic Name | Codeine Phosphate, Phenylephrine Hydrochloride, Chlorpheniramine Maleate |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-10-08 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Capital Pharmaceutical, LLC |
| Substance Name | CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE |
| Active Ingredient Strength | 10 mg/5mL; mg/5mL; mg/5mL |
| DEA Schedule | CV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2010-10-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-10-08 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-12 |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-10-08 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-03-12 |
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 10 mg/5mL |
| SPL SET ID: | 1b281052-55e3-42c0-86ae-585799d97960 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CAPCOF 90709129 not registered Live/Pending |
Nevett, Michael 2021-05-13 |